MapLight Therapeutics Funding: $699M Raised, Series D (2025)
MapLight Therapeutics is a Biotech company based in Redwood City, California. It has raised $699M in total funding. Latest round: Series D.
MapLight Therapeutics funding overview
MapLight Therapeutics is a Biotech company based in Redwood City, California. MapLight Therapeutics has raised $699M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in July 2025. The round record for MapLight Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Forbion, Life Sciences at Goldman Sachs Alternatives, Sanofi, T. Rowe Price Investment Management, Inc., Avego BioScience Capital, Novo Holdings and 2 others. 8 distinct backers are named across the disclosed rounds.
MapLight Therapeutics at a glance
Total raised
$699M
Latest round
Series D
Latest round date
July 2025
Industry
Biotech
Headquarters
Redwood City, California
Notable investors
Forbion, Life Sciences at Goldman Sachs Alternatives, Sanofi, T. Rowe Price Investment Management, Inc., Avego BioScience Capital, Novo Holdings, 5AM Ventures, Blue Owl Healthcare Opportunities
Frequently asked about MapLight Therapeutics funding
How much has MapLight Therapeutics raised?
MapLight Therapeutics has raised $699M in total disclosed funding across the rounds on record.
Who has invested in MapLight Therapeutics?
Forbion, Life Sciences at Goldman Sachs Alternatives, Sanofi, T. Rowe Price Investment Management, Inc., Avego BioScience Capital, Novo Holdings are named among the investors backing MapLight Therapeutics.
What was the latest MapLight Therapeutics funding round?
The most recent disclosed round is a Series D, announced in July 2025.
Where is MapLight Therapeutics based?
MapLight Therapeutics is based in Redwood City, California.
What sector does MapLight Therapeutics operate in?
MapLight Therapeutics is tracked under Biotech from Redwood City, California, with $699M in disclosed funding.
When did MapLight Therapeutics last raise?
The last disclosed MapLight Therapeutics round closed in July 2025 at Series D.
MapLight Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Redwood City below to benchmark round size and investor mix.
